Skip to content
value.today

Applied Genetic Technologies Corp.

Total raised
$42 M
2 rounds on record
Latest round
$9 M
Nov 2012
First round on record
Nov 2003
Today
Private
See the company page

Applied Genetic Technologies Corp. is listed today as Applied Genetic Technologies Corporation: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Applied Genetic Technologies Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2012$9 MNo. 2$2 to $10 million

Applied Genetic Technologies Corp.: Raise no. 2, Nov 2012

Investors in this round

9 investors had bought by the notice of Nov 29, 2012: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Applied Genetic Technologies Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $38 M offered; $29 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Susan B Washer · Executive Officer, Director
  • Arnold B Oronsky · Director
  • Edward B Hurwitz · Director
  • James B Rosen · Director
  • Kent B Gossett · Director
  • Samuel B Wu · Director
  • Scott B Koenig · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Susan B. Washer, President and CEO. Source: SEC Form D, newest notice filed Nov 29, 2012. Read the notice at the SEC.

equitySEC
Nov 2003$34 MNo. 1$10 to $50 million

Applied Genetic Technologies Corp.: Raise no. 1, Nov 2003

Investors in this round

11 investors had bought by the notice of Jul 16, 2009: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Applied Genetic Technologies Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$34 M of $39 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,250,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Susan B Washer · Executive Officer, Director
  • Arnold Oronsky · Director
  • Frank Top · Director
  • Garheng Kong · Director
  • Nicholas Muzyczka · Director
  • Scott Koenig · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Susan B Washer, President and chief executive officer. Source: SEC Form D, newest notice filed Jul 16, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Applied Genetic Technologies Corp. chose not to state its revenue in its newest notice of a funding round (Nov 2012).

    SEC Form D · Nov 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2012

That is all the official record says: Applied Genetic Technologies Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Applied Genetic Technologies Corp. are on record.

Investors#

8 named in official filings. Open an investor to see everything it has backed.

Investors in Applied Genetic Technologies Corp.
InvestorKindAmountRoundRoleSource
Alta Partners Management VIII, LLCFund or asset managernot statednot statedHeld Series B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Alta Partners VIII, L.P.Fund or asset managernot statednot statedHeld Series B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
GSK PLCFund or asset managernot statednot statedHeld Series B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Interwest Investors Q VIII LPFund or asset managernot statednot statedHeld Series A-1, B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Interwest Investors VIII L.P.Fund or asset managernot statednot statedHeld Series A-1, B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
InterWest Management Partners VIII, LLCFund or asset managernot statednot statedHeld Series A-1, B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Interwest Partners VIII LPFund or asset managernot statednot statedHeld Series A-1, B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
MedImmune Ventures, Inc.Venture capitalnot statednot statedHeld Series A-1A, B-1, B-2 and B-3 preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Applied Genetic Technologies Corp.
NameRoleNamed in
Susan B WasherExecutive officerNov 2012
Arnold B OronskyDirectorNov 2012
Edward B HurwitzDirectorNov 2012
James B RosenDirectorNov 2012
Kent B GossettDirectorNov 2012
Samuel B WuDirectorNov 2012
Scott B KoenigDirectorNov 2012
Susan B WasherDirectorNov 2012
Arnold OronskyDirectorJul 2009
Frank TopDirectorJul 2009
Garheng KongDirectorJul 2009
Nicholas MuzyczkaDirectorJul 2009
Scott KoenigDirectorJul 2009

About

Biotechnology company.